[go: up one dir, main page]

EA200801777A1 - α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ - Google Patents

α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ

Info

Publication number
EA200801777A1
EA200801777A1 EA200801777A EA200801777A EA200801777A1 EA 200801777 A1 EA200801777 A1 EA 200801777A1 EA 200801777 A EA200801777 A EA 200801777A EA 200801777 A EA200801777 A EA 200801777A EA 200801777 A1 EA200801777 A1 EA 200801777A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
pharmaceutical compositions
crystal form
arginine salt
here contains
Prior art date
Application number
EA200801777A
Other languages
English (en)
Other versions
EA014716B1 (ru
Inventor
Жерар Кокерель
Луа Лефебвре
Жан-Клод Сувье
Паскаль Отуар
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37022969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801777(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200801777A1 publication Critical patent/EA200801777A1/ru
Publication of EA014716B1 publication Critical patent/EA014716B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

α кристаллическая форма соединения формулы (I) : которая характеризуется ее рентгеновской дифракционной порошкограммой. Лекарственные средства.
EA200801777A 2006-02-28 2007-02-26 α-КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ EA014716B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601748A FR2897866B1 (fr) 2006-02-28 2006-02-28 Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000335 WO2007099217A1 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE α DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (2)

Publication Number Publication Date
EA200801777A1 true EA200801777A1 (ru) 2009-02-27
EA014716B1 EA014716B1 (ru) 2011-02-28

Family

ID=37022969

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801777A EA014716B1 (ru) 2006-02-28 2007-02-26 α-КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ

Country Status (28)

Country Link
US (1) US7846961B2 (ru)
EP (1) EP1989182B1 (ru)
JP (1) JP5255454B2 (ru)
KR (2) KR20080106948A (ru)
CN (1) CN101389603B (ru)
AU (1) AU2007220435B2 (ru)
BR (1) BRPI0708278B8 (ru)
CA (1) CA2644467C (ru)
CY (1) CY1117753T1 (ru)
DK (1) DK1989182T3 (ru)
EA (1) EA014716B1 (ru)
ES (1) ES2581982T3 (ru)
FR (1) FR2897866B1 (ru)
GE (1) GEP20125433B (ru)
HK (1) HK1129669A1 (ru)
HR (1) HRP20160644T1 (ru)
HU (1) HUE027898T2 (ru)
MA (1) MA30276B1 (ru)
ME (1) ME02456B (ru)
MY (1) MY151035A (ru)
NO (1) NO20083535L (ru)
NZ (1) NZ570367A (ru)
PL (1) PL1989182T3 (ru)
RS (1) RS54754B1 (ru)
SI (1) SI1989182T1 (ru)
UA (1) UA89905C2 (ru)
WO (1) WO2007099217A1 (ru)
ZA (1) ZA200807024B (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022573B1 (ru) * 2012-01-05 2016-01-29 Ле Лаборатуар Сервье Способ получения l-аргининовой соли периндоприла
EA022574B1 (ru) * 2012-01-05 2016-01-29 Ле Лаборатуар Сервье Дельта кристаллическая форма аргининовой соли периндоприла, способ ее получения и содержащие ее фармацевтические композиции

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2318365T3 (en) * 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357B (zh) * 2021-12-29 2024-06-25 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
DK2318365T3 (en) 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022573B1 (ru) * 2012-01-05 2016-01-29 Ле Лаборатуар Сервье Способ получения l-аргининовой соли периндоприла
EA022574B1 (ru) * 2012-01-05 2016-01-29 Ле Лаборатуар Сервье Дельта кристаллическая форма аргининовой соли периндоприла, способ ее получения и содержащие ее фармацевтические композиции

Also Published As

Publication number Publication date
DK1989182T3 (en) 2016-07-25
WO2007099217A1 (fr) 2007-09-07
CN101389603B (zh) 2012-07-04
JP5255454B2 (ja) 2013-08-07
FR2897866B1 (fr) 2008-04-18
JP2009534295A (ja) 2009-09-24
HK1129669A1 (ru) 2009-12-04
CA2644467A1 (fr) 2007-09-07
EP1989182B1 (fr) 2016-04-13
RS54754B1 (sr) 2016-10-31
BRPI0708278B8 (pt) 2021-05-25
US20090203758A1 (en) 2009-08-13
PL1989182T3 (pl) 2016-09-30
CY1117753T1 (el) 2017-05-17
FR2897866A1 (fr) 2007-08-31
KR20120001818A (ko) 2012-01-04
SI1989182T1 (sl) 2016-07-29
MY151035A (en) 2014-03-31
BRPI0708278A2 (pt) 2011-05-24
GEP20125433B (en) 2012-03-26
MA30276B1 (fr) 2009-03-02
CA2644467C (fr) 2011-07-26
BRPI0708278B1 (pt) 2021-03-02
UA89905C2 (ru) 2010-03-10
EA014716B1 (ru) 2011-02-28
AU2007220435A1 (en) 2007-09-07
ME02456B (me) 2017-02-20
AU2007220435B2 (en) 2010-11-04
US7846961B2 (en) 2010-12-07
NO20083535L (no) 2008-08-14
ZA200807024B (en) 2010-04-28
KR20080106948A (ko) 2008-12-09
HUE027898T2 (en) 2016-10-28
EP1989182A1 (fr) 2008-11-12
CN101389603A (zh) 2009-03-18
NZ570367A (en) 2011-03-31
ES2581982T3 (es) 2016-09-08
HRP20160644T1 (hr) 2016-07-01

Similar Documents

Publication Publication Date Title
EA200802119A1 (ru) Новая кристаллическая форма vi агомелатина, способ его получения и фармацевтические композиции, которые ее содержат
EA200601271A1 (ru) Новая кристаллическая форма iv агомелатина, способ её получения и фармацевтические композиции, которые её содержат
EA200801777A1 (ru) α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
EA200601273A1 (ru) Новая кристаллическая форма v агомелатина, способ её получения и фармацевтические композиции, которые её содержат
EA200601274A1 (ru) Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат
MY143557A (en) Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
EA200600323A1 (ru) γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
EA200970156A1 (ru) Пиридизиноновые производные
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA201101026A1 (ru) Ингибиторы бета-секретазы
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201190293A1 (ru) Пролекарства триптолида
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA201270302A1 (ru) Безводные формы производных пиридина
EA201201668A1 (ru) Δ-кристаллическая форма аргининовой соли периндоприла, способ ее получения и содержащие ее фармацевтические композиции
EA201100502A1 (ru) Гликозидные производные и их применения
EA200900936A1 (ru) Аморфные и кристаллические формы ривастигмина гидротартрата
EA200970708A1 (ru) Фармацевтические композиции, включающие аторвастатин и никотиновую кислоту
EA201000882A1 (ru) Соединение, его применение и фармацевтическая композиция, содержащая это соединение
EA200971031A1 (ru) Моногидрохлориды ингибитора гистондеацетилазы
TNSN05076A1 (en) New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it